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Summary.-Mammalian cells (V79-379A) in suspension culture rendered chronically
hypoxic showed greater resistance to Adriamycin than exponentially growing
aerobic cells. Resistance to Adriamycin increased as a function of the time cells were
held under hypoxic conditions, with maximal resistance after 6 h. Chronically
hypoxic cells retained their resistance when reoxygenated, and did not return to their
original sensitivity until they had been in air for 24 h. Uptake of Adriamycin was
similar for chronically hypoxic and exponentially growing aerobic cells, but much
more than for plateau-phase cells. These findings suggest that chronically hypoxic
cells in tumours may be resistant to this drug.
IT HAS LONG been suspected that the
radio resistance of hypoxic cells may be a
limiting factor in the treatment of some
human tumours by radiotherapy. How-
ever, the possibility that such hypoxic
cells may also be a problem in the treat-
ment of cancer by chemotherapy has,
until recently, received much less atten-
tion. There are good grounds, however, for
suspecting that such cells may be more
drug-resistant than aerobic cells. Firstly,
cells which are potentially clonogenic but
rendered temporarily hypoxic may be-
come non-cycling or at least slow down in
their progression through the mitotic
cycle. Secondly, hypoxic cells tend to be
located near necrotic, or poorly-vascu-
larized regions in tumours and may be
less accessible to cytotoxic drugs. We are
examining the effects of the degree and
duration of hypoxia on the response of
mammalian cells exposed in vitro to a
range of chemotherapeutic drugs. This
report is concerned with the response of
oxic and hypoxic Chinese hamster cells
exposed to the drug Adriamycin under
various conditions.
MATERIALS AND METHODS
The maintenance and culture of the
Chinese hamster V79-379A cells used in this
work have been reported elsewhere (Stratford
& Adams, 1977).
Toxicity experiments were carried out by
suspending cells in full growth medium
(Eagle's Minimum Essential Medium, MEM,
plus 7-5% foetal calf serum, FCS) in spinner
flasks fitted with a gas inlet/outlet system and
a sidearm through which samples could be
withdrawn. Flasks containing about 100 ml
of a suspension containing asynchronous log-
phase cells at a concentration ofabout 5 x 105
cells/ml were placed in a water bath at 37°C.
Adriamvcin was dissolved in distilled water
at a concentration of 200 ,ug/ml and diluted
appropriately in MEM+7-5% FCS. Drug was
then added to cell suspensions and samples
withdrawn at appropriate intervals after the
initial inoculation. Cells were washed free of
drug by centrifugation and resuspension,
counted, serially diluted, plated in MEM+
15% FCS and incubated at 37°C in 950 air+
5% CO2. Survival was taken as the ability of
a single cell to form a visible colony 7-10
days after plating. Plating efficiency for this
cell line in our hands was routinely >950o.
Cells were rendered hypoxic by flowing N2
containing 500 CO2 (BOC Ltd) at 500 ml/min
over the surface of the stirred suspension at
37°C. The 02 concentration in the effluent
gas was steady at < 10 pts/106 after about 1 h
and this degree of hypoxia was maintained
by a continuous flow of N2 throughout the
experiment. After the required time under
hypoxic conditions, a deoxygenated solutionCYTOTOXICITY OF ADRIAMYCIN ON HYPOXIC CELLS
of Adriamycin was added to the cell suspen- 1
sion via the stoppered port. In some experi-
ments cells were rendered "chronically"
hypoxic by de-aeration for 16 h before
exposure to Adriamycin. This time under -
hypoxia did not significantly alter plating 10
efficiency.
Drug uptake was measured by the tech-
nique of Bachur et al. (1970) which measures
Adriamycin equivalents from the fluorescence
oftheanthracycline structure. Sinceallknown '0
cellular metabolic products of Adriamycin 2 contain this structure, the procedure can be
used to follow uptake. However, the tech- s .5 nique does not allow the resolution of active >
and inactive products. X 1i6
RESULTS
Exponentially growing aerobic cells 4
were exposed to various concentrations of
Adriamycin at 37°C, and the surviving
fractions measured (Fig. 1). The survival
ofcells is dependent upon both the contact
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FIG. 2.-The effect of varying Adriamycin
0\ \ o concentrations for 1 h at 37°C. (0) Expo-
0' \\ \O \ nential aerobic cells; (0) cells previously 10 \ \maintained under hypoxia for 16 h at
o 0-5pg/ml 370C (3 replicate experiments); (LI) cells
previously maintained under hypoxia at
150C (2 replicate experiments).
.10-2k \ 1Oj.ig/ml time and the concentration ofAdriamycin
in the medium.
The response of aerobic exponential-
phase cells to Adriamycin contrasts mark-
'n 1-03 \ \ edly with that of exponential cells ren-
dered chronically hypoxic by deoxygena-
a 20,ugftl tion overnight (16 h at 37°C) before ex-
posure to drug. Fig. 2 shows survival data
for cells exposed to a range ofAdriamycin
concentrations for 1 h in air at 37°C. Cells
° 4 5Oiglml rendered chronically hypoxic at 370C
prior to being given Adriamycin are much
more resistant than exponential cells
C time 4) which are continually aerobic. The magni- Contact time (h
FIG. 1.-The survival of exponentially tude ofthis resistance can be comparedby
growing Chinese hamster cells in the examining the survival of cells exposed to
presence of varying concentrations of 5 ,g/ml Adriamycin for 1 h. For exponen-
Adriamycin in air at 370C for up to 5 h. tial cells, the surviving fraction is 2-5 x Data points are the means from 3 experi- 10v ments. ; in contrast survival of the chronic-
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FIG. 3. The effect of different gassing times Time in air (h )
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cells at 37°C prior to subsequent treatment FIa. 4.-The effect of 5 iLg/mlAdr'amycn at at g ml pdrior yto bsequent treate 37°C in chronically hypoxic cells after re-
ox ygenation for varying times, 30 m mn,
cate experiments). Dashied curve represents (xy) h (O) 2 h, (0) 4 h, (+ 9 h(m2
exponentially growing aerobic cells treated ermets, ( A) 4 h,
'th 5 ttg/lAdr'amyin in air replicate experiments), ( A) 24 h (2 replicate wilth 5 ,ug/ml Adlriamycin in air. experiments). The dashed line represents
exponentially growing aerobic cells treated
ally hypoxic cells is only reduced to
2-5 x 10-1. Fig. 2 also shows that the
hypoxia-induced resistance to Adriamycin
is dependent on the temperature at which
the cells are rendered hypoxic. When this
is done at 15°C, cells subsequently show
no resistance to Adriamycin (open squares
in Fig. 2). This may indicate that hypoxia-
induced metabolic processes are important
in causing the resistance to Adriamycin
and suggests that the time cells are held
under hypoxic conditions at 37°C would
influence their resistance to this drug.
Fig. 3 shows survival curves for cells ex-
posed to 5 tg/ml Adriamycin for different
periods of time in N2 at 37°C. Cells de-
aerated for 1 h show no significant differ-
ence in response from those cells held con-
tinuously in air and treated with Adria-
witui ug/ml Airiamycin in air.
mycin in air. However, as the time the
cells are hypoxic increases, the resistance
to Adriamycin also increases. Maximum
resistance occurs after de-aeration for 6 h.
Further experiments were carried out to
ascertain whether the acquired resistance
is maintained when the cells are oxygen-
ated after the hypoxic treatment but
before exposure to Adriamycin. The re-
sults are given in Fig. 4, where chronically
hypoxic cells (de-aeration for 16 h) were
exposed to 02 for different times before
exposure to 5 ,ug/ml Adriamycin in 02- It
can be seen that after re-oxygenation the
cells still remain resistant for up to 9 h;
only after 24 h in air do the cells become
as sensitive to Adriamycin as those cells
10
.2 u
C
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which have not undergone any hypoxic
treatment.
Workers have previously shown that
aerobic cells in plateau phase are more
resistant to Adriamycin than aerobic cells
in exponential phase (Krishan & Frei,
1976; Twentyman, 1976; Martin &
McNally, 1979; Sutherland et al., 1979).
We have carried out some similar experi-
ments in order to make a direct com-
parison of the sensitiveness of aerobic
plateau-phase cellsandchronicallyhypoxic
cells. Fig. 5 compares survival data for
plateau-phase and exponential-phase cells
exposed to Adriamycin at 37TC in air. In
this experiment cells were grown to
plateau phase (1.5 x 106 cells/ml) and then
treated with various concentrations of
Platecu
2 o 102''
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FIG. 5.-The survival of exponential and
plateau-phase cells treated with varying
concentrations ofAdriamycin at 37°Cfor 1 h.
Error bars represent the s.d. of 4-8 experi-
ments, and illustrate the magnitude of
errors obtained for all the reported survival
data.
Adriamycin for 1 h. Firstly, plateau-phase
aerobic cells are much more resistant than
exponential aerobic cells, confirming the
earlier published data. Secondly, the
plateau-phase cells are at least as re-
sistant as the chronically hypoxic cells.
The relative resistance of plateau-
phase cells to Adriamycin has been
attributed to a less efficient uptake of
drug (Sutherland et al., 1979; Harris et al.,
1979). We have carried out drug-uptake
experiments with chronically hypoxic
cells. Chronically hypoxic, aerobic plateau-
phase and aerobic exponential-phase cells
were exposed to various concentrations of
Adriamycin for 1 h. Cells were then centri-
fuged, washed and the number of Adria-
mycin equivalents per cell estimated.
Fig. 6 shows that drug uptake into
plateau-phase cells is much less than into
exponential cells, which in turn take up
less drug than chronically hypoxic cells.
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FIG. 6.-Uptake ofdifferent concentrations of
Adriamycin into aerobic, chronically
hypoxic and plateau-phase cells after
incubation at 37'C for 1 h. Measurements
indicate means of 2 experiments.
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DISCUSSION
It is known that exponentially growing
cells in a culture which is rendered
chronically hypoxic show more resistance
than normally proliferating cells to bleo-
mycin (Roizin-Towle & Hall, 1978),
Actinomycin D (Adams et al., 1980) and
5-fluorouracil, cytosine arabinoside and
vincristine (Smith et al., 1979).
Sutherland and colleagues (1979) in-
vestigated the cytotoxic action of Adria-
mycin in EMT6 tumour cells growing as
spheroids in vitro. They found that Adria-
mycin was less effective in killing cells in
spheroids than monolayer cells, either in
exponential or plateau-phase. It was pro-
posed that only the peripheral cells of the
spheroid take up cytotoxic concentrations
of the drug. In support, it was found that
cells from dissociated spheroids take up
more drug than those in intact spheroids,
suggesting a diffusion gradient for the
penetration of Adriamycin into spheroids.
Notwithstanding these results, Sutherland
and colleagues were able to show that the
cells in the central regions ofthe spheroids
were most drug-resistant. They concluded
that this resistance was not due to differ-
ences in the cell-cycle stage of the inner
cells, since it was found that exponential
and plateau-phase monolayer cells were
about equally sensitive when the surviving
fraction was plotted as a function of
absorbed drug. Thus, other factors related
to the metabolic state ofthe cells or to the
microenvironment were thought to be in-
volved in resistance to Adriamycin
(Sutherland et al., 1979).
The in vitro results in this paper demon-
strate that chronically hypoxic cells are
resistant to the cytotoxic action of Adria-
mycin. This is not a consequence of cellu-
lar uptake of Adriamycin, since the
exponential-phase and chronically hypoxic
cells take up similar amounts of the drug.
Cells need to be held under hypoxic con-
ditions at 37°C for 6 h or more before
resistance to Adriamycin becomes maxi-
mal. However, resistance is not observed
when cells are held in N2 at 15°C, which
makes it likely that hypoxia-induced
metabolic processes render cells less sus-
ceptible to damage by Adriamycin.
Resistance to the cytotoxic action of
Adriamycin is not lost when the chronic-
ally hypoxic cells are reoxygenated. Oxy-
genation for 24 h at 37°C is required for
cells to return to their original sensitivity,
which is a time similar to that required for
these cells to return to a state where
exponential growth kinetics are observed
(E. Smith, unpublished). Clearly, the
toxicity of Adriamycin does not depend
directly on the presence of 02. This is
further illustrated by comparison of the
sensitivities of acutely hypoxic cells (1 h
under N2) and aerobic exponential cells,
where exposure to Adriamycin results in
similar levels of cell killing.
It is concluded that metabolic changes
induced in cells by prolonged hypoxia can
alter cellular sensitivity to Adriamycin.
The results suggest that hypoxia may play
an important role, therefore, in determin-
ing the response of some solid tumours to
treatment regimes containing Adriamycin.
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